{"ticker": {"uuid": "122f93db-84ce-4726-9104-b2a4f819cb44", "symbol": "OPRX", "name": "OPTIMIZERx Corp", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Health Information Services"}, "articles": [{"title": "OptimizeRx Launches CopayCue\u2122, a Next-Generation Copay Activation Solution Powered by Real-Time Prescribing Intent", "summary": "OptimizeRx has launched CopayCue\u2122, a new solution designed to increase the transparency of brand savings offers for physicians within the e-prescribing workflow. This technology uses real-time HCP prescribing intent data to deliver copay card and affordability information, aiming", "url": "https://www.manilatimes.net/2026/06/30/tmt-newswire/globenewswire/optimizerx-launches-copaycue-a-next-generation-copay-activation-solution-powered-by-real-time-prescribing-intent/2375672/amp", "source_name": "The Manila Times", "published_at": "2026-06-30T19:42:00", "published_display": "30 Jun 2026 19:42", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OptimizeRx stock rises after launching CopayCue product", "summary": "OptimizeRx Corp (NASDAQ:OPRX) shares rose after the company announced the launch of CopayCue, a new product designed to deliver brand savings offers directly within healthcare professionals' prescribing workflows. This technology aims to address medication affordability issues, w", "url": "https://www.investing.com/news/stock-market-news/optimizerx-stock-rises-after-launching-copaycue-product-93CH-4767929", "source_name": "Investing.com", "published_at": "2026-06-30T13:09:08", "published_display": "30 Jun 2026 13:09", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OptimizeRx Corporation (OPRX) Stock Price | Live Quotes & Charts | NASDAQ", "summary": "This article provides live stock quotes and charts for OptimizeRx Corporation (OPRX), detailing its current stock price, daily change, and percentage change. It notes the absence of recent analyst ratings and earnings information. The content also features promotional material fo", "url": "https://stockstotrade.com/quote/OPRX", "source_name": "StocksToTrade", "published_at": "2026-06-30T13:09:08", "published_display": "30 Jun 2026 13:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OptimizeRx stock rises after launching CopayCue product By Investing.com", "summary": "OptimizeRx Corp (NASDAQ:OPRX) shares rose after the company announced the launch of CopayCue, a new technology designed to deliver brand savings offers within the prescribing workflow. CopayCue aims to address medication affordability issues by providing copay cards and affordabi", "url": "https://m.au.investing.com/news/stock-market-news/optimizerx-stock-rises-after-launching-copaycue-product-93CH-4511400?ampMode=1", "source_name": "Investing.com Australia", "published_at": "2026-06-30T12:40:31", "published_display": "30 Jun 2026 12:40", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OptimizeRx launches CopayCue for prescription savings", "summary": "OptimizeRx Corp. has launched CopayCue, a new technology designed to deliver prescription savings offers directly to physicians during the prescribing process, aiming to improve medication affordability and patient access. The solution has shown a significant increase in prescrip", "url": "https://www.investing.com/news/company-news/optimizerx-launches-copaycue-for-prescription-savings-93CH-4767575", "source_name": "Investing.com", "published_at": "2026-06-30T12:09:08", "published_display": "30 Jun 2026 12:09", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OptimizeRx ties copay offers to physician intent at prescribing moment", "summary": "OptimizeRx (Nasdaq: OPRX) has launched CopayCue, a new solution that delivers brand savings offers directly within e-prescribing workflows by leveraging real-time healthcare professional (HCP) prescribing intent data. This aims to overcome medication affordability barriers, which", "url": "https://www.stocktitan.net/news/OPRX/optimize-rx-launches-copay-cue-tm-a-next-generation-copay-activation-qml53lkw7qb0.html", "source_name": "Stock Titan", "published_at": "2026-06-30T11:40:30", "published_display": "30 Jun 2026 11:40", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Stifel reiterates Buy on OptimizeRX stock, cites AI tool launch By Investing.com", "summary": "Stifel maintained a Buy rating and $14.00 price target on OptimizeRX (NASDAQ: OPRX) after the company launched an AI-powered tool called Natural Language Audience Builder. Despite recent stock decline, InvestingPro analysis suggests the company is undervalued and analysts expect ", "url": "https://m.au.investing.com/news/stock-market-news/stifel-reiterates-buy-on-optimizerx-stock-cites-ai-tool-launch-93CH-4508970?ampMode=1", "source_name": "Investing.com Australia", "published_at": "2026-06-29T12:14:18", "published_display": "29 Jun 2026 12:14", "sentiment": "positive", "sentiment_pct": 74, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OptimizeRx stock rating maintained at Market Outperform by Citizens", "summary": "Citizens has maintained a Market Outperform rating on OptimizeRx (NASDAQ: OPRX) with a $9.00 price target, indicating a 77% upside from its current trading price despite a recent 58% decline. The firm highlighted OptimizeRx's undervalued status according to InvestingPro analysis ", "url": "https://www.investing.com/news/analyst-ratings/optimizerx-stock-rating-maintained-at-market-outperform-by-citizens-93CH-4764546", "source_name": "Investing.com", "published_at": "2026-06-29T09:14:18", "published_display": "29 Jun 2026 09:14", "sentiment": "positive", "sentiment_pct": 72, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 93, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OptimizeRx Corporation(NasdaqCM: OPRX) dropped from Russell 2000 Dynamic Index", "summary": "OptimizeRx Corporation (NasdaqCM: OPRX) has been removed from the Russell 2000 Dynamic Index, as reported on MarketScreener. This announcement follows several recent company updates, including a change in its Chief Commercial Officer role and integration of its EHR network into a", "url": "https://www.marketscreener.com/news/optimizerx-corporation-nasdaqcm-oprx-dropped-from-russell-2000-dynamic-index-ce7f5fded881f423", "source_name": "marketscreener.com", "published_at": "2026-06-29T01:09:47", "published_display": "29 Jun 2026 01:09", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Stifel reiterates Buy on OptimizeRX stock, cites AI tool launch", "summary": "Stifel maintained a Buy rating and $14.00 price target for OptimizeRX (NASDAQ: OPRX) after the company launched a new AI-powered tool. The Natural Language Audience Builder is designed to help pharmaceutical and agency marketers build custom healthcare provider audiences. Despite", "url": "https://www.investing.com/news/analyst-ratings/stifel-reiterates-buy-on-optimizerx-stock-cites-ai-tool-launch-93CH-4765232", "source_name": "Investing.com", "published_at": "2026-06-28T07:41:18", "published_display": "28 Jun 2026 07:41", "sentiment": "positive", "sentiment_pct": 64, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OptimizeRx Launches Natural Language Audience Builder for Life Sciences DSPs and Agency Media Planning Platforms", "summary": "OptimizeRx has launched a Natural Language Audience Builder aimed at enhancing audience precision for life sciences digital signal processors (DSPs) and agency media planning platforms. This new tool leverages AI and deep learning to identify and refine healthcare professional (H", "url": "https://www.moomoo.com/news/post/72034360/optimizerx-launches-natural-language-audience-builder-for-life-sciences-dsps", "source_name": "Moomoo", "published_at": "2026-06-26T02:40:00", "published_display": "26 Jun 2026 02:40", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Citizens reiterates Market Outperform on OptimizeRX stock at forum By Investing.com", "summary": "Citizens has reiterated a \"Market Outperform\" rating and a $9.00 price target for OptimizeRx (NASDAQ: OPRX) stock, despite the stock trading near its 52-week low. InvestingPro analysis suggests the company is undervalued, with a P/E ratio of 13.44 and a 16% free cash flow yield. ", "url": "https://ng.investing.com/news/stock-market-news/citizens-reiterates-market-outperform-on-optimizerx-stock-at-forum-93CH-2573520", "source_name": "Investing.com Nigeria", "published_at": "2026-06-26T02:40:00", "published_display": "26 Jun 2026 02:40", "sentiment": "positive", "sentiment_pct": 63, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OptimizeRx puts HCP audience building inside ad-buying platforms", "summary": "OptimizeRx (Nasdaq: OPRX) has launched its Natural Language Audience Builder (NLAB), an AI-powered tool that allows life sciences companies and agencies to build, refine, and activate custom healthcare provider (HCP) audiences using natural-language prompts. This patent-pending t", "url": "https://www.stocktitan.net/news/OPRX/optimize-rx-launches-natural-language-audience-builder-for-life-s0yn3maynnqt.html", "source_name": "Stock Titan", "published_at": "2026-06-25T11:12:04", "published_display": "25 Jun 2026 11:12", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Citizens reiterates Market Outperform on OptimizeRX stock at forum", "summary": "Citizens reiterated a Market Outperform rating and $9.00 price target on OptimizeRx (NASDAQ:OPRX) shares, despite the stock trading near its 52-week low after a 63% decline in six months. The firm is hosting its annual Healthcare Services Forum where OptimizeRX will present, alon", "url": "https://m.investing.com/news/analyst-ratings/citizens-reiterates-market-outperform-on-optimizerx-stock-at-forum-93CH-4759950?ampMode=1", "source_name": "Investing.com", "published_at": "2026-06-25T09:12:04", "published_display": "25 Jun 2026 09:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 93, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OptimizeRx Corp (OPRX) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of OptimizeRx Corp (OPRX), focusing on its price momentum, support and resistance levels, and various technical indicators and moving averages. The stock currently has a price momentum score of 6.55 and is trading between a resistance le", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-oprx/technical", "source_name": "TradingKey", "published_at": "2026-06-24T01:41:14", "published_display": "24 Jun 2026 01:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OptimizeRx Corp (OPRX) Valuation: PE, PB & Fair Value Analysis", "summary": "This article provides a valuation analysis of OptimizeRx Corp (OPRX), highlighting its current valuation score of 8.20 within the Software & IT Services industry. It notes the company's current P/E ratio of 12.67, comparing it to recent highs and lows. The analysis also indicates", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-oprx/company-valuation", "source_name": "TradingKey", "published_at": "2026-06-23T09:39:15", "published_display": "23 Jun 2026 09:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OptimizeRx Corp (OPRX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article provides a revenue breakdown for OptimizeRx Corp (OPRX), detailing its stock performance, market capitalization, and P/E ratio. It notes that relevant data regarding business segments, regional revenue, and profit contribution have not yet been disclosed by the compa", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-oprx/revenue", "source_name": "TradingKey", "published_at": "2026-06-18T10:39:31", "published_display": "18 Jun 2026 10:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OptimizeRx Corp (OPRX) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides an overview of OptimizeRx Corp's (OPRX) dividend and stock split history. It notes that the company has distributed $0.00 in dividends over the past five years and shows no record of stock splits. The page also presents current stock performance data, includ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-oprx/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-18T10:39:31", "published_display": "18 Jun 2026 10:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OptimizeRx Corp (OPRX) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "This article details the shareholder structure of OptimizeRx Corp (OPRX), listing its major individual and institutional holders, their proportion of shares, and recent changes in holdings. It also provides a breakdown of shareholder types by investment category and historical in", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-oprx/ownership", "source_name": "TradingKey", "published_at": "2026-06-18T10:39:31", "published_display": "18 Jun 2026 10:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OptimizeRx Corp (OPRX) Risk Assessment: Volatility, Financial Risk & Investment Risk", "summary": "This article provides a risk assessment for OptimizeRx Corp (OPRX), highlighting its current risk score of 4.19 within the Software & IT Services industry. The company's beta of 1.14 suggests it is more volatile than the S&P 500. The assessment includes detailed metrics on volati", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-oprx/risk-assesment", "source_name": "TradingKey", "published_at": "2026-06-17T21:10:33", "published_display": "17 Jun 2026 21:10", "sentiment": "negative", "sentiment_pct": 37, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OptimizeRx Corp (OPRX) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "OptimizeRx Corp (OPRX) currently holds an earnings forecast score of 8.67, ranking it 26th in the Software & IT Services industry. Analysts project an average price target of $24.00, with a consensus \"Buy\" rating based on 6 analyst reports. The company's next expected revenue is ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-oprx/earnings", "source_name": "TradingKey", "published_at": "2026-06-17T20:10:00", "published_display": "17 Jun 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OptimizeRx (OPRX) Stock Sees Fair Value Cut As Analysts Reset Growth Expectations", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOazhjcnlydE1uQTIwWDJZX0N0T1VpM2xhTXpRbGxfZ2FhT3Nwak56MHFwaURGZjkxWUtQeklZUnhtdG0xSjR0ZDFvTDdsRWp5dENCRlpkNW9qU0FsNjZwaWRId3g1OGxsMTZBRHU4MWRqQ2VkcHFENDlueXV4LXAzTVpWdTZUZjJRUkpPYUJ1TS0xRXJaRGlKd0JadDY?oc=5", "source_name": "Market source", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OptimizeRx Corp (OPRX) Institutional Confidence", "summary": "OptimizeRx Corp (OPRX) has an institutional shareholding score of 7.00, placing it 140th out of 489 in the Software & IT Services industry. Institutional investors hold 82.46% of shares, an increase of 8.32% quarter-over-quarter. The largest institutional shareholder is Bill Nygr", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-oprx/sentiment", "source_name": "TradingKey", "published_at": "2026-06-16T22:10:00", "published_display": "16 Jun 2026 22:10", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OptimizeRx (OPRX) director awarded 17,258 restricted stock units in Form 4 filing", "summary": "OptimizeRx Corp director Presti Mariyamma Varghese was granted 17,258 restricted stock units (RSUs) of common stock, increasing her direct holdings to 30,318 shares. This award was provided at no cash cost per unit and signifies a contingent right to receive shares. The RSUs will", "url": "https://www.stocktitan.net/sec-filings/OPRX/form-4-optimize-rx-corp-insider-trading-activity-be6635dd4403.html", "source_name": "Stock Titan", "published_at": "2026-06-15T12:11:41", "published_display": "15 Jun 2026 12:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OptimizeRx (NASDAQ: OPRX) holders add 1M plan shares, reject evergreen", "summary": "OptimizeRx shareholders approved an amendment to the 2021 Equity Incentive Plan, increasing the shares available for awards by 1,000,000 to a total of 5,450,000. While all director nominees were elected and executive compensation was approved on an advisory basis, a proposal to a", "url": "https://www.stocktitan.net/sec-filings/OPRX/8-k-optimize-rx-corp-reports-material-event-3ab737cbd1ff.html", "source_name": "Stock Titan", "published_at": "2026-06-12T20:10:15", "published_display": "12 Jun 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OPRX SEC Filings - Optimizerx Corp 10-K, 10-Q, 8-K Forms", "summary": "This page provides a comprehensive resource for Optimizerx (OPRX) SEC filings, including 10-K, 10-Q, 8-K forms, and insider trading reports. Recent filings detail equity awards for executives Edward Stelmakh, Theresa Greco, and Doug Besch, an amended employment letter for Brendan", "url": "https://www.stocktitan.net/sec-filings/OPRX/page-5.html", "source_name": "Stock Titan", "published_at": "2026-06-12T08:10:15", "published_display": "12 Jun 2026 08:10", "sentiment": "positive", "sentiment_pct": 61, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Optimizerx Corporation (OPRX) Affects Rotational Strategy Timing", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxNNVo5aE5tSldCd1JadnQyQTByQm5GdWU5NGJDV25WRlBSQUdWNGtKWWRVZFpldW1WRm5CVFN4SGhBeGpHU2N6SUhuMUctTmVkV21oNzRoMHlyclZ0dWdWLWpzYzE1YjI2LVFvSm5vY1JZTnRwN3lPTlhOeDFsYWh0SWlXenVIV1puTWRGbWE3NkoySHVZM0RObHV2S19lck9Bd2J6aTdDMzNKa2FZdFBLWHJnRGdvR2xaMGVqanp5OHNZV1duT2liT1NSNG5VM2R3Vm5aN1ZwTm1RMWxFTHc?oc=5", "source_name": "Stock Traders Daily", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OptimizeRx: A Good Business That Has Not Yet Earned Back Investor Trust", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/optimizerx-good-business-not-yet-123315725.html", "source_name": "GuruFocus.com", "published_at": "2026-06-09T12:33:15+00:00", "published_display": "09 Jun 2026 12:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OptimizeRx to Participate in Upcoming Investor Conferences", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/optimizerx-participate-upcoming-investor-conferences-113000892.html", "source_name": "GlobeNewswire", "published_at": "2026-06-01T11:30:00+00:00", "published_display": "01 Jun 2026 11:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OptimizeRx vs. Doximity: Which Digital Health Stock Is the Better Bet?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxOcGFKN0hpRDd3NnRNNmN0N0ZiUTdKVzV0T0tBZF9weXF1V0tZdmdNZjhFVFNaSFhJZ0UwX1VyQXVkZ0V3QV9Xd1JZcnFwTnIxVWlfaTZ2Nms4d0k0RnlFeXhCbEdxdGFib0VrRF8wcXNyM3hPS1FEdmI2T1BTRnVGc2NVSEpSWDlKTlVlamwzRXVSbFdwLTVTN1hXRkMyUUVpNG1sdld6SVNCUQ?oc=5", "source_name": "Market source", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DeepIntent Becomes First Healthcare DSP to Integrate OptimizeRx\u2019s Authenticated EHR Network", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/deepintent-becomes-first-healthcare-dsp-113000240.html", "source_name": "GlobeNewswire", "published_at": "2026-05-21T11:30:00+00:00", "published_display": "21 May 2026 11:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OptimizeRx Stock Down 30% in a Month: Should Investors Hold or Fold?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNN2tvVVQ0eFFndDEyT09xekIyLU5pZV9VTWNIT01GMEVaZ3B6eWVQWi1DWHkxdk9mQXZFZ2xTLXhhdjIyRlBqeS1ON1VsTFAtQzZRTE0zelNTdFBDZWtRemgyWHZNM3lfYWlhUHlVaXVWOWxrRjF1b210eFdtOExsbEFzUklXckkxdXhTalVnUl9xcUUwQWQwc053WQ?oc=5", "source_name": "Market source", "published_at": "2026-05-20T07:00:00+00:00", "published_display": "20 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OptimizeRx Cuts Revenue Outlook: Will Pressures Ease Ahead?", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/optimizerx-cuts-revenue-outlook-pressures-140900052.html", "source_name": "Zacks", "published_at": "2026-05-15T14:09:00+00:00", "published_display": "15 May 2026 14:09", "sentiment": "negative", "sentiment_pct": 42, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Need To Know: Analysts Just Made A Substantial Cut To Their OptimizeRx Corporation (NASDAQ:OPRX) Estimates", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OptimizeRx Corporation (OPRX) Releases Q1 2026 Earnings: Revenue Down but Beats; EPS Miss", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxPYUdHTUl5dFYzcHcxWW50ZDU4dkY4c09HQmZPYVRyYWZyVElLZTUtdDNuRDh2ZVc0cUhJWUQxVE9aZml3WUc4TTlabk94TWlIZE9lUnNPS1RjZDNydWowYXltTXZtUW50QmkyUW5TRGlLQWNERTlHeXFlWURsQ2xDOTB1YUh1eThpTWJ4YTNfZk9BTjluRXF5VkdKSVNiUXMzZ2xLYTlhaVNsZWozWEg3V24tMzg5Y1FfaWNRb0ZocVA1YlBHbGpkU3ln?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OptimizeRx Corp. (OPRX) Surpasses Q1 Earnings and Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxOQTJnRW9LN2N4bkY4Y2MxeV9relhkU2Vnc3hXZ291SUxLMGNrbV9EeU15ZnlEX2xJYXdmZTVITlAxaHkyY055ZTF2REpJd1pESjUxRi1pTE1scXh4MHNTb3NTV25HZlVUa3FHNTVIOF9ac3NMdkRwQWZKbFlHb08weFFIYWlYQQ?oc=5", "source_name": "Market source", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings Preview: OptimizeRx Corp. (OPRX) Q1 Earnings Expected to Decline", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxORVJ6bHBGMWxDYS1oZ3R6d21qQmYyQ0xhNGhTZWZvYXMzcjdFTmRMNFQ4dmxPOGRPMUxVNnJGVjBmVmlUOTNLOWQtZUNBR1VzQlc3TjNfRHJyNmtOTVVBTXN6VnRLZlM1dnMtZE9OYi1XTGVGdkZjVUYtTVNxZFZJNnNZem1ONVA0dzdOY1Z1UUpNRXhtTGtXRGxidC1tSWNUSTVfZQ?oc=5", "source_name": "Market source", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OptimizeRx vs. GoodRx: Which Digital Health Stock is the Better Buy?", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxOVmxlV05GbUZJdWNubHllUzQ3N0JHRVJvdGpOZkNyMklwVEd3MTNwTVlOWm1mZGVNUVU4M0l5TVUyZDZRaWxrVFBlNzkzSUV5OWY5bDFWTEI1TDZmY080Z19DZFBVdmYxenl1S2hEbzVfclpzSE91b0JETFhhekQyQzg5dDFZeGJvVGZ0ZzVTSnE3MlItYjZBenV2ZG5vLWVLSTR3VjJVTQ?oc=5", "source_name": "Market source", "published_at": "2026-04-24T07:00:00+00:00", "published_display": "24 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The OptimizeRx (OPRX) Narrative Is Shifting As Revenue Caution Meets Profit Optimism", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxOYVIzSklkSjBlY1R2N2Q4SlEzbC0tc1ZUYlhTN1V2YllYMDlyZEpLVTZKY3FnYjN1OXZKTFlGNUJoQkdINTFVWldnQ1lEVHV5Nk5wcXdBbmlaaUxubFNZcUU0SnZuWmhIaFB5Vi1vOHBzSldweTk5NVhEdTh6bVRkYlFfcDZaSmZ0VmRzTDNlOGc2V2ppODlTRF9kVFQ0NmVxMy0zaHRKdHBPRzQ?oc=5", "source_name": "Market source", "published_at": "2026-04-18T07:00:00+00:00", "published_display": "18 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Should Value Investors Buy OptimizeRx (OPRX) Stock?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxQejJNRHpUdmxia1RiS2xDc05WYWpKTHpZUm1PWTlkTU5DT0dEeVNLa0h5VTE0U2k2UXd6VWxuX25kWnRsUEpPNWZYcHVMa01wRFlKNEE4XzJjSVRNMHVNWkJ3TkxieGpydW4xTnNINnpWRkl3OUc3amJLN2dEaExfOWFVSVFFZEZscGNGajBKVkFWUGVYMzdwSEM5WXNSV2JPMnc?oc=5", "source_name": "Market source", "published_at": "2026-04-17T07:00:00+00:00", "published_display": "17 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OptimizeRx (OPRX) Soars 5.9%: Is Further Upside Left in the Stock?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxQbXFPNk5qZVREUFBvTUtxMEpiUzBKRXNnd1V3bE05Q1lTV0J5SlJISVBMR0Q0d3g2aWtqM3BZd3FBZndlNXJuYjZNblp2UVllc2VCT2RtZmhOWW5CNEI4MmNMUEl5OVNWU0IyQkc5ZHNNNTBEcEVtcWs1YU1HSEhRWXl6aHQ2OFU1UXBfak5GdEFoaE1p?oc=5", "source_name": "Market source", "published_at": "2026-03-26T07:00:00+00:00", "published_display": "26 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is OptimizeRx Stock Built to Withstand More Downside?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxPTlVtLVY5NWtwTUE2RW44MENwMzYxZUdpMExJMFdIeFBjSHpweHVHalNLOFJVblRYaGxkYXdKOVlPU0JiNlFEV1h0MzByZDEwSnV5a3VGdnBRWEpybWN3emVkTlpRSTcxYVJjLXEwWWxRRDUxZnpEbXF0dnVfMFp2VmZFdXZhUEFoNGtOX1YzS0NnLU13VURLRG5KZGt6LW9BUWJHQnB3eFIxSEJMSGgtYzljbEUxV3k2TFRjUjdRUnE?oc=5", "source_name": "Trefis", "published_at": "2025-12-20T08:00:00+00:00", "published_display": "20 Dec 2025 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Optimizerx", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTE1GaThxdHowVFZNTzlzcDZ6d2tHWVJLV2tTbGo4Tk9meEUtdGU5dWVHWDVMSlBpd2JIY0M1OTlaN3l6elUzWVJoM05nbUJ5Z2E2MmpodkVGOA?oc=5", "source_name": "Forbes", "published_at": "2025-11-07T08:00:00+00:00", "published_display": "07 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Optimizerx (OPRX) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE5UMHhFb01wSlhNcUJCY0tGVzVZMEdncHc4dTk0bHlOZU5iaU9jUG9MN3JIUWxqVkNnZzZNNmk5ejZ3Um1YbldJdlh3Y2lQNzJRVzdn?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-24T23:15:17+00:00", "published_display": "24 Apr 2025 23:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Optimizerx (OPRX) Stock News & Updates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiTkFVX3lxTFBxRFVSLXBIRGhIbzRraW84WGw1SDRJbnMyRjNGaTZWdUc2M0x0ZjBsYi1SX3o0bE54YXdDTWN1MTFmM0JqQWJvUjVPeUVyQQ?oc=5", "source_name": "Stock Titan", "published_at": "2020-09-06T05:26:06+00:00", "published_display": "06 Sep 2020 05:26", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "OptimizeRx Launches CopayCue\u2122, a Next-Generation Copay Activation Solution Powered by Real-Time Prescribing Intent", "summary": "OptimizeRx has launched CopayCue\u2122, a new solution designed to increase the transparency of brand savings offers for physicians within the e-prescribing workflow. This technology uses real-time HCP prescribing intent data to deliver copay card and affordability information, aiming", "url": "https://www.manilatimes.net/2026/06/30/tmt-newswire/globenewswire/optimizerx-launches-copaycue-a-next-generation-copay-activation-solution-powered-by-real-time-prescribing-intent/2375672/amp", "source_name": "The Manila Times", "published_at": "2026-06-30T19:42:00", "published_display": "30 Jun 2026 19:42", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OptimizeRx stock rises after launching CopayCue product", "summary": "OptimizeRx Corp (NASDAQ:OPRX) shares rose after the company announced the launch of CopayCue, a new product designed to deliver brand savings offers directly within healthcare professionals' prescribing workflows. This technology aims to address medication affordability issues, w", "url": "https://www.investing.com/news/stock-market-news/optimizerx-stock-rises-after-launching-copaycue-product-93CH-4767929", "source_name": "Investing.com", "published_at": "2026-06-30T13:09:08", "published_display": "30 Jun 2026 13:09", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OptimizeRx Corporation (OPRX) Stock Price | Live Quotes & Charts | NASDAQ", "summary": "This article provides live stock quotes and charts for OptimizeRx Corporation (OPRX), detailing its current stock price, daily change, and percentage change. It notes the absence of recent analyst ratings and earnings information. The content also features promotional material fo", "url": "https://stockstotrade.com/quote/OPRX", "source_name": "StocksToTrade", "published_at": "2026-06-30T13:09:08", "published_display": "30 Jun 2026 13:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OptimizeRx stock rises after launching CopayCue product By Investing.com", "summary": "OptimizeRx Corp (NASDAQ:OPRX) shares rose after the company announced the launch of CopayCue, a new technology designed to deliver brand savings offers within the prescribing workflow. CopayCue aims to address medication affordability issues by providing copay cards and affordabi", "url": "https://m.au.investing.com/news/stock-market-news/optimizerx-stock-rises-after-launching-copaycue-product-93CH-4511400?ampMode=1", "source_name": "Investing.com Australia", "published_at": "2026-06-30T12:40:31", "published_display": "30 Jun 2026 12:40", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OptimizeRx launches CopayCue for prescription savings", "summary": "OptimizeRx Corp. has launched CopayCue, a new technology designed to deliver prescription savings offers directly to physicians during the prescribing process, aiming to improve medication affordability and patient access. The solution has shown a significant increase in prescrip", "url": "https://www.investing.com/news/company-news/optimizerx-launches-copaycue-for-prescription-savings-93CH-4767575", "source_name": "Investing.com", "published_at": "2026-06-30T12:09:08", "published_display": "30 Jun 2026 12:09", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OptimizeRx ties copay offers to physician intent at prescribing moment", "summary": "OptimizeRx (Nasdaq: OPRX) has launched CopayCue, a new solution that delivers brand savings offers directly within e-prescribing workflows by leveraging real-time healthcare professional (HCP) prescribing intent data. This aims to overcome medication affordability barriers, which", "url": "https://www.stocktitan.net/news/OPRX/optimize-rx-launches-copay-cue-tm-a-next-generation-copay-activation-qml53lkw7qb0.html", "source_name": "Stock Titan", "published_at": "2026-06-30T11:40:30", "published_display": "30 Jun 2026 11:40", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Stifel reiterates Buy on OptimizeRX stock, cites AI tool launch By Investing.com", "summary": "Stifel maintained a Buy rating and $14.00 price target on OptimizeRX (NASDAQ: OPRX) after the company launched an AI-powered tool called Natural Language Audience Builder. Despite recent stock decline, InvestingPro analysis suggests the company is undervalued and analysts expect ", "url": "https://m.au.investing.com/news/stock-market-news/stifel-reiterates-buy-on-optimizerx-stock-cites-ai-tool-launch-93CH-4508970?ampMode=1", "source_name": "Investing.com Australia", "published_at": "2026-06-29T12:14:18", "published_display": "29 Jun 2026 12:14", "sentiment": "positive", "sentiment_pct": 74, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OptimizeRx stock rating maintained at Market Outperform by Citizens", "summary": "Citizens has maintained a Market Outperform rating on OptimizeRx (NASDAQ: OPRX) with a $9.00 price target, indicating a 77% upside from its current trading price despite a recent 58% decline. The firm highlighted OptimizeRx's undervalued status according to InvestingPro analysis ", "url": "https://www.investing.com/news/analyst-ratings/optimizerx-stock-rating-maintained-at-market-outperform-by-citizens-93CH-4764546", "source_name": "Investing.com", "published_at": "2026-06-29T09:14:18", "published_display": "29 Jun 2026 09:14", "sentiment": "positive", "sentiment_pct": 72, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 93, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OptimizeRx Corporation(NasdaqCM: OPRX) dropped from Russell 2000 Dynamic Index", "summary": "OptimizeRx Corporation (NasdaqCM: OPRX) has been removed from the Russell 2000 Dynamic Index, as reported on MarketScreener. This announcement follows several recent company updates, including a change in its Chief Commercial Officer role and integration of its EHR network into a", "url": "https://www.marketscreener.com/news/optimizerx-corporation-nasdaqcm-oprx-dropped-from-russell-2000-dynamic-index-ce7f5fded881f423", "source_name": "marketscreener.com", "published_at": "2026-06-29T01:09:47", "published_display": "29 Jun 2026 01:09", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Stifel reiterates Buy on OptimizeRX stock, cites AI tool launch", "summary": "Stifel maintained a Buy rating and $14.00 price target for OptimizeRX (NASDAQ: OPRX) after the company launched a new AI-powered tool. The Natural Language Audience Builder is designed to help pharmaceutical and agency marketers build custom healthcare provider audiences. Despite", "url": "https://www.investing.com/news/analyst-ratings/stifel-reiterates-buy-on-optimizerx-stock-cites-ai-tool-launch-93CH-4765232", "source_name": "Investing.com", "published_at": "2026-06-28T07:41:18", "published_display": "28 Jun 2026 07:41", "sentiment": "positive", "sentiment_pct": 64, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OptimizeRx Launches Natural Language Audience Builder for Life Sciences DSPs and Agency Media Planning Platforms", "summary": "OptimizeRx has launched a Natural Language Audience Builder aimed at enhancing audience precision for life sciences digital signal processors (DSPs) and agency media planning platforms. This new tool leverages AI and deep learning to identify and refine healthcare professional (H", "url": "https://www.moomoo.com/news/post/72034360/optimizerx-launches-natural-language-audience-builder-for-life-sciences-dsps", "source_name": "Moomoo", "published_at": "2026-06-26T02:40:00", "published_display": "26 Jun 2026 02:40", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Citizens reiterates Market Outperform on OptimizeRX stock at forum By Investing.com", "summary": "Citizens has reiterated a \"Market Outperform\" rating and a $9.00 price target for OptimizeRx (NASDAQ: OPRX) stock, despite the stock trading near its 52-week low. InvestingPro analysis suggests the company is undervalued, with a P/E ratio of 13.44 and a 16% free cash flow yield. ", "url": "https://ng.investing.com/news/stock-market-news/citizens-reiterates-market-outperform-on-optimizerx-stock-at-forum-93CH-2573520", "source_name": "Investing.com Nigeria", "published_at": "2026-06-26T02:40:00", "published_display": "26 Jun 2026 02:40", "sentiment": "positive", "sentiment_pct": 63, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OptimizeRx puts HCP audience building inside ad-buying platforms", "summary": "OptimizeRx (Nasdaq: OPRX) has launched its Natural Language Audience Builder (NLAB), an AI-powered tool that allows life sciences companies and agencies to build, refine, and activate custom healthcare provider (HCP) audiences using natural-language prompts. This patent-pending t", "url": "https://www.stocktitan.net/news/OPRX/optimize-rx-launches-natural-language-audience-builder-for-life-s0yn3maynnqt.html", "source_name": "Stock Titan", "published_at": "2026-06-25T11:12:04", "published_display": "25 Jun 2026 11:12", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Citizens reiterates Market Outperform on OptimizeRX stock at forum", "summary": "Citizens reiterated a Market Outperform rating and $9.00 price target on OptimizeRx (NASDAQ:OPRX) shares, despite the stock trading near its 52-week low after a 63% decline in six months. The firm is hosting its annual Healthcare Services Forum where OptimizeRX will present, alon", "url": "https://m.investing.com/news/analyst-ratings/citizens-reiterates-market-outperform-on-optimizerx-stock-at-forum-93CH-4759950?ampMode=1", "source_name": "Investing.com", "published_at": "2026-06-25T09:12:04", "published_display": "25 Jun 2026 09:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 93, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OptimizeRx Corp (OPRX) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of OptimizeRx Corp (OPRX), focusing on its price momentum, support and resistance levels, and various technical indicators and moving averages. The stock currently has a price momentum score of 6.55 and is trading between a resistance le", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-oprx/technical", "source_name": "TradingKey", "published_at": "2026-06-24T01:41:14", "published_display": "24 Jun 2026 01:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OptimizeRx Corp (OPRX) Valuation: PE, PB & Fair Value Analysis", "summary": "This article provides a valuation analysis of OptimizeRx Corp (OPRX), highlighting its current valuation score of 8.20 within the Software & IT Services industry. It notes the company's current P/E ratio of 12.67, comparing it to recent highs and lows. The analysis also indicates", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-oprx/company-valuation", "source_name": "TradingKey", "published_at": "2026-06-23T09:39:15", "published_display": "23 Jun 2026 09:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OptimizeRx Corp (OPRX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article provides a revenue breakdown for OptimizeRx Corp (OPRX), detailing its stock performance, market capitalization, and P/E ratio. It notes that relevant data regarding business segments, regional revenue, and profit contribution have not yet been disclosed by the compa", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-oprx/revenue", "source_name": "TradingKey", "published_at": "2026-06-18T10:39:31", "published_display": "18 Jun 2026 10:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OptimizeRx Corp (OPRX) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides an overview of OptimizeRx Corp's (OPRX) dividend and stock split history. It notes that the company has distributed $0.00 in dividends over the past five years and shows no record of stock splits. The page also presents current stock performance data, includ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-oprx/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-18T10:39:31", "published_display": "18 Jun 2026 10:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OptimizeRx Corp (OPRX) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "This article details the shareholder structure of OptimizeRx Corp (OPRX), listing its major individual and institutional holders, their proportion of shares, and recent changes in holdings. It also provides a breakdown of shareholder types by investment category and historical in", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-oprx/ownership", "source_name": "TradingKey", "published_at": "2026-06-18T10:39:31", "published_display": "18 Jun 2026 10:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OptimizeRx Corp (OPRX) Risk Assessment: Volatility, Financial Risk & Investment Risk", "summary": "This article provides a risk assessment for OptimizeRx Corp (OPRX), highlighting its current risk score of 4.19 within the Software & IT Services industry. The company's beta of 1.14 suggests it is more volatile than the S&P 500. The assessment includes detailed metrics on volati", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-oprx/risk-assesment", "source_name": "TradingKey", "published_at": "2026-06-17T21:10:33", "published_display": "17 Jun 2026 21:10", "sentiment": "negative", "sentiment_pct": 37, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OptimizeRx Corp (OPRX) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "OptimizeRx Corp (OPRX) currently holds an earnings forecast score of 8.67, ranking it 26th in the Software & IT Services industry. Analysts project an average price target of $24.00, with a consensus \"Buy\" rating based on 6 analyst reports. The company's next expected revenue is ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-oprx/earnings", "source_name": "TradingKey", "published_at": "2026-06-17T20:10:00", "published_display": "17 Jun 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OptimizeRx (OPRX) Stock Sees Fair Value Cut As Analysts Reset Growth Expectations", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOazhjcnlydE1uQTIwWDJZX0N0T1VpM2xhTXpRbGxfZ2FhT3Nwak56MHFwaURGZjkxWUtQeklZUnhtdG0xSjR0ZDFvTDdsRWp5dENCRlpkNW9qU0FsNjZwaWRId3g1OGxsMTZBRHU4MWRqQ2VkcHFENDlueXV4LXAzTVpWdTZUZjJRUkpPYUJ1TS0xRXJaRGlKd0JadDY?oc=5", "source_name": "Market source", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OptimizeRx Corp (OPRX) Institutional Confidence", "summary": "OptimizeRx Corp (OPRX) has an institutional shareholding score of 7.00, placing it 140th out of 489 in the Software & IT Services industry. Institutional investors hold 82.46% of shares, an increase of 8.32% quarter-over-quarter. The largest institutional shareholder is Bill Nygr", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-oprx/sentiment", "source_name": "TradingKey", "published_at": "2026-06-16T22:10:00", "published_display": "16 Jun 2026 22:10", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OptimizeRx (OPRX) director awarded 17,258 restricted stock units in Form 4 filing", "summary": "OptimizeRx Corp director Presti Mariyamma Varghese was granted 17,258 restricted stock units (RSUs) of common stock, increasing her direct holdings to 30,318 shares. This award was provided at no cash cost per unit and signifies a contingent right to receive shares. The RSUs will", "url": "https://www.stocktitan.net/sec-filings/OPRX/form-4-optimize-rx-corp-insider-trading-activity-be6635dd4403.html", "source_name": "Stock Titan", "published_at": "2026-06-15T12:11:41", "published_display": "15 Jun 2026 12:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OptimizeRx (NASDAQ: OPRX) holders add 1M plan shares, reject evergreen", "summary": "OptimizeRx shareholders approved an amendment to the 2021 Equity Incentive Plan, increasing the shares available for awards by 1,000,000 to a total of 5,450,000. While all director nominees were elected and executive compensation was approved on an advisory basis, a proposal to a", "url": "https://www.stocktitan.net/sec-filings/OPRX/8-k-optimize-rx-corp-reports-material-event-3ab737cbd1ff.html", "source_name": "Stock Titan", "published_at": "2026-06-12T20:10:15", "published_display": "12 Jun 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OPRX SEC Filings - Optimizerx Corp 10-K, 10-Q, 8-K Forms", "summary": "This page provides a comprehensive resource for Optimizerx (OPRX) SEC filings, including 10-K, 10-Q, 8-K forms, and insider trading reports. Recent filings detail equity awards for executives Edward Stelmakh, Theresa Greco, and Doug Besch, an amended employment letter for Brendan", "url": "https://www.stocktitan.net/sec-filings/OPRX/page-5.html", "source_name": "Stock Titan", "published_at": "2026-06-12T08:10:15", "published_display": "12 Jun 2026 08:10", "sentiment": "positive", "sentiment_pct": 61, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Optimizerx Corporation (OPRX) Affects Rotational Strategy Timing", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxNNVo5aE5tSldCd1JadnQyQTByQm5GdWU5NGJDV25WRlBSQUdWNGtKWWRVZFpldW1WRm5CVFN4SGhBeGpHU2N6SUhuMUctTmVkV21oNzRoMHlyclZ0dWdWLWpzYzE1YjI2LVFvSm5vY1JZTnRwN3lPTlhOeDFsYWh0SWlXenVIV1puTWRGbWE3NkoySHVZM0RObHV2S19lck9Bd2J6aTdDMzNKa2FZdFBLWHJnRGdvR2xaMGVqanp5OHNZV1duT2liT1NSNG5VM2R3Vm5aN1ZwTm1RMWxFTHc?oc=5", "source_name": "Stock Traders Daily", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OptimizeRx: A Good Business That Has Not Yet Earned Back Investor Trust", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/optimizerx-good-business-not-yet-123315725.html", "source_name": "GuruFocus.com", "published_at": "2026-06-09T12:33:15+00:00", "published_display": "09 Jun 2026 12:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OptimizeRx to Participate in Upcoming Investor Conferences", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/optimizerx-participate-upcoming-investor-conferences-113000892.html", "source_name": "GlobeNewswire", "published_at": "2026-06-01T11:30:00+00:00", "published_display": "01 Jun 2026 11:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OptimizeRx vs. Doximity: Which Digital Health Stock Is the Better Bet?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxOcGFKN0hpRDd3NnRNNmN0N0ZiUTdKVzV0T0tBZF9weXF1V0tZdmdNZjhFVFNaSFhJZ0UwX1VyQXVkZ0V3QV9Xd1JZcnFwTnIxVWlfaTZ2Nms4d0k0RnlFeXhCbEdxdGFib0VrRF8wcXNyM3hPS1FEdmI2T1BTRnVGc2NVSEpSWDlKTlVlamwzRXVSbFdwLTVTN1hXRkMyUUVpNG1sdld6SVNCUQ?oc=5", "source_name": "Market source", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DeepIntent Becomes First Healthcare DSP to Integrate OptimizeRx\u2019s Authenticated EHR Network", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/deepintent-becomes-first-healthcare-dsp-113000240.html", "source_name": "GlobeNewswire", "published_at": "2026-05-21T11:30:00+00:00", "published_display": "21 May 2026 11:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OptimizeRx Stock Down 30% in a Month: Should Investors Hold or Fold?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNN2tvVVQ0eFFndDEyT09xekIyLU5pZV9VTWNIT01GMEVaZ3B6eWVQWi1DWHkxdk9mQXZFZ2xTLXhhdjIyRlBqeS1ON1VsTFAtQzZRTE0zelNTdFBDZWtRemgyWHZNM3lfYWlhUHlVaXVWOWxrRjF1b210eFdtOExsbEFzUklXckkxdXhTalVnUl9xcUUwQWQwc053WQ?oc=5", "source_name": "Market source", "published_at": "2026-05-20T07:00:00+00:00", "published_display": "20 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OptimizeRx Cuts Revenue Outlook: Will Pressures Ease Ahead?", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/optimizerx-cuts-revenue-outlook-pressures-140900052.html", "source_name": "Zacks", "published_at": "2026-05-15T14:09:00+00:00", "published_display": "15 May 2026 14:09", "sentiment": "negative", "sentiment_pct": 42, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Need To Know: Analysts Just Made A Substantial Cut To Their OptimizeRx Corporation (NASDAQ:OPRX) Estimates", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OptimizeRx Corporation (OPRX) Releases Q1 2026 Earnings: Revenue Down but Beats; EPS Miss", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxPYUdHTUl5dFYzcHcxWW50ZDU4dkY4c09HQmZPYVRyYWZyVElLZTUtdDNuRDh2ZVc0cUhJWUQxVE9aZml3WUc4TTlabk94TWlIZE9lUnNPS1RjZDNydWowYXltTXZtUW50QmkyUW5TRGlLQWNERTlHeXFlWURsQ2xDOTB1YUh1eThpTWJ4YTNfZk9BTjluRXF5VkdKSVNiUXMzZ2xLYTlhaVNsZWozWEg3V24tMzg5Y1FfaWNRb0ZocVA1YlBHbGpkU3ln?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OptimizeRx Corp. (OPRX) Surpasses Q1 Earnings and Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxOQTJnRW9LN2N4bkY4Y2MxeV9relhkU2Vnc3hXZ291SUxLMGNrbV9EeU15ZnlEX2xJYXdmZTVITlAxaHkyY055ZTF2REpJd1pESjUxRi1pTE1scXh4MHNTb3NTV25HZlVUa3FHNTVIOF9ac3NMdkRwQWZKbFlHb08weFFIYWlYQQ?oc=5", "source_name": "Market source", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings Preview: OptimizeRx Corp. (OPRX) Q1 Earnings Expected to Decline", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxORVJ6bHBGMWxDYS1oZ3R6d21qQmYyQ0xhNGhTZWZvYXMzcjdFTmRMNFQ4dmxPOGRPMUxVNnJGVjBmVmlUOTNLOWQtZUNBR1VzQlc3TjNfRHJyNmtOTVVBTXN6VnRLZlM1dnMtZE9OYi1XTGVGdkZjVUYtTVNxZFZJNnNZem1ONVA0dzdOY1Z1UUpNRXhtTGtXRGxidC1tSWNUSTVfZQ?oc=5", "source_name": "Market source", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OptimizeRx vs. GoodRx: Which Digital Health Stock is the Better Buy?", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxOVmxlV05GbUZJdWNubHllUzQ3N0JHRVJvdGpOZkNyMklwVEd3MTNwTVlOWm1mZGVNUVU4M0l5TVUyZDZRaWxrVFBlNzkzSUV5OWY5bDFWTEI1TDZmY080Z19DZFBVdmYxenl1S2hEbzVfclpzSE91b0JETFhhekQyQzg5dDFZeGJvVGZ0ZzVTSnE3MlItYjZBenV2ZG5vLWVLSTR3VjJVTQ?oc=5", "source_name": "Market source", "published_at": "2026-04-24T07:00:00+00:00", "published_display": "24 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The OptimizeRx (OPRX) Narrative Is Shifting As Revenue Caution Meets Profit Optimism", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxOYVIzSklkSjBlY1R2N2Q4SlEzbC0tc1ZUYlhTN1V2YllYMDlyZEpLVTZKY3FnYjN1OXZKTFlGNUJoQkdINTFVWldnQ1lEVHV5Nk5wcXdBbmlaaUxubFNZcUU0SnZuWmhIaFB5Vi1vOHBzSldweTk5NVhEdTh6bVRkYlFfcDZaSmZ0VmRzTDNlOGc2V2ppODlTRF9kVFQ0NmVxMy0zaHRKdHBPRzQ?oc=5", "source_name": "Market source", "published_at": "2026-04-18T07:00:00+00:00", "published_display": "18 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Should Value Investors Buy OptimizeRx (OPRX) Stock?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxQejJNRHpUdmxia1RiS2xDc05WYWpKTHpZUm1PWTlkTU5DT0dEeVNLa0h5VTE0U2k2UXd6VWxuX25kWnRsUEpPNWZYcHVMa01wRFlKNEE4XzJjSVRNMHVNWkJ3TkxieGpydW4xTnNINnpWRkl3OUc3amJLN2dEaExfOWFVSVFFZEZscGNGajBKVkFWUGVYMzdwSEM5WXNSV2JPMnc?oc=5", "source_name": "Market source", "published_at": "2026-04-17T07:00:00+00:00", "published_display": "17 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OptimizeRx (OPRX) Soars 5.9%: Is Further Upside Left in the Stock?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxQbXFPNk5qZVREUFBvTUtxMEpiUzBKRXNnd1V3bE05Q1lTV0J5SlJISVBMR0Q0d3g2aWtqM3BZd3FBZndlNXJuYjZNblp2UVllc2VCT2RtZmhOWW5CNEI4MmNMUEl5OVNWU0IyQkc5ZHNNNTBEcEVtcWs1YU1HSEhRWXl6aHQ2OFU1UXBfak5GdEFoaE1p?oc=5", "source_name": "Market source", "published_at": "2026-03-26T07:00:00+00:00", "published_display": "26 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is OptimizeRx Stock Built to Withstand More Downside?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxPTlVtLVY5NWtwTUE2RW44MENwMzYxZUdpMExJMFdIeFBjSHpweHVHalNLOFJVblRYaGxkYXdKOVlPU0JiNlFEV1h0MzByZDEwSnV5a3VGdnBRWEpybWN3emVkTlpRSTcxYVJjLXEwWWxRRDUxZnpEbXF0dnVfMFp2VmZFdXZhUEFoNGtOX1YzS0NnLU13VURLRG5KZGt6LW9BUWJHQnB3eFIxSEJMSGgtYzljbEUxV3k2TFRjUjdRUnE?oc=5", "source_name": "Trefis", "published_at": "2025-12-20T08:00:00+00:00", "published_display": "20 Dec 2025 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Optimizerx", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTE1GaThxdHowVFZNTzlzcDZ6d2tHWVJLV2tTbGo4Tk9meEUtdGU5dWVHWDVMSlBpd2JIY0M1OTlaN3l6elUzWVJoM05nbUJ5Z2E2MmpodkVGOA?oc=5", "source_name": "Forbes", "published_at": "2025-11-07T08:00:00+00:00", "published_display": "07 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Optimizerx (OPRX) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE5UMHhFb01wSlhNcUJCY0tGVzVZMEdncHc4dTk0bHlOZU5iaU9jUG9MN3JIUWxqVkNnZzZNNmk5ejZ3Um1YbldJdlh3Y2lQNzJRVzdn?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-24T23:15:17+00:00", "published_display": "24 Apr 2025 23:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Optimizerx (OPRX) Stock News & Updates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiTkFVX3lxTFBxRFVSLXBIRGhIbzRraW84WGw1SDRJbnMyRjNGaTZWdUc2M0x0ZjBsYi1SX3o0bE54YXdDTWN1MTFmM0JqQWJvUjVPeUVyQQ?oc=5", "source_name": "Stock Titan", "published_at": "2020-09-06T05:26:06+00:00", "published_display": "06 Sep 2020 05:26", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 92, "total_relevant": 45, "sentiment_summary": {"positive": 17, "negative": 6, "neutral": 22, "score": 56, "total": 45, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 83, "events": [{"event": "general", "label": "Market update", "weight": 16.5, "count": 30}, {"event": "earnings", "label": "Earnings", "weight": 4.75, "count": 8}, {"event": "analyst", "label": "Analyst action", "weight": 2.75, "count": 5}, {"event": "capital_return", "label": "Capital return", "weight": 0.55, "count": 1}, {"event": "liquidity", "label": "Balance sheet", "weight": 0.55, "count": 1}], "positive_events": 17, "negative_events": 6}, "market_context": {"has_market_context": true, "latest_close": 6.41, "latest_week": "2026-07-10", "one_week_move": 3.6, "four_week_move": 22.6, "twelve_week_move": -10.6, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.622754, "market_dynamics_buy_signal": false, "relative_strength": -53.811407, "fair_value_gap": -37.9, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 42.4437, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+3.6% over one week, +22.6% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 66, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 9}, {"label": "TradingKey", "count": 8}, {"label": "Stock Titan", "count": 7}, {"label": "Investing.com", "count": 5}, {"label": "Investing.com Australia", "count": 2}, {"label": "GlobeNewswire", "count": 2}, {"label": "The Manila Times", "count": 1}, {"label": "StocksToTrade", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 45}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 30}, {"label": "Earnings", "count": 8}, {"label": "Analyst action", "count": 5}, {"label": "Capital return", "count": 1}, {"label": "Balance sheet", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "56/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "83/100 classification confidence."}, {"label": "Company focus", "value": "45", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+3.6% over one week, +22.6% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "OptimizeRx Launches CopayCue\u2122, a Next-Generation Copay Activation Solution Powered by Real-Time Prescribing Intent"}], "updated_at": "2026-07-16T10:34:47.553428+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}